Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE–BIG 01–04) for women with stage II/III breast cancer

✍ Scribed by R.E. Coleman; E.J. Woodward*; J.E. Brown; D. Cameron; R. Bell; D. Dodwell; M. Keane; M. Gil; C. Davies; R. Burkinshaw; S.J. Houston; R.J. Grieve; P.J. Barrett-Lee; H. Thorpe

• Book ID: 116324000
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 54 KB
• Volume: 48
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2010.10.079